Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 56,400 shares traded.
Resverlogix Trading Up 5.0%
The company’s 50-day moving average is C$0.10 and its 200 day moving average is C$0.10. The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11. The firm has a market cap of C$33.28 million, a PE ratio of -5.25 and a beta of 0.41.
Resverlogix (TSE:RVX – Get Free Report) last announced its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share (EPS) for the quarter. As a group, sell-side analysts predict that Resverlogix Corp. will post -0.22 EPS for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
